Inhibikase Therapeutics Inc. – Filings and Transcripts

NASDAQ: IKT
Share price (11/6/26): $1.50
Market cap (11/6/26): $209 million

Warning: Large portions of this site require JavaScript enabled in order to function properly. Please make sure JavaScript is enabled in your browser.

Please let us know at support@bamsec.com if you have any questions or concerns.

Search in Documents

Key Exhibits

External Links

Financials Filter

ended 06/30/26 Q2

ended 03/31/26 Q1

ended 12/31/25 FY 2025

ended 09/30/25 Q3

ended 06/30/25 Q2

Prospectuses and Registrations Filter

Registration of securities for employees

Registration of securities for employees

Prospectus supplement for primary offering

Prospectus supplement for primary offering

Prospectus supplement for primary offering

Ownership Filter

Wasserman Scott M.

Wasserman Scott M.

Perceptive Advisors LLC

Nantahala Capital Management, LLC

Sands Capital Life Sciences Pulse Fund II, L.P.

News Filter

Appoints Scott Wasserman to Board of Directors

Investor Presentation

Change in Certifying Accountant, Financial Statements or Exhibits

Announces Second Quarter 2026 Financial Results and Highlights Recent Activity

Unregistered Sales of Equity Securities, Financial Statements or Exhibits

Proxies Filter

Additional info about upcoming vote

Definitive proxy

Preliminary proxy

Additional info about upcoming vote

Additional info about upcoming vote

Other Filter

Scanned paper annual report submission

Notice of effectiveness

Correspondence with the SEC

Letter from the SEC

Scanned paper annual report submission